A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples